Surgical indications for hepatocellular adenoma: Diagnostic uncertainty and molecular risk stratification
Drug Discoveries & Therapeutics · 31.10.2026 · 20 (5) · 405-408
DOI: 10.5582/ddt.2026.01086 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Discoveries & Therapeutics, erschienen am 31.10.2026. Verfasst von Jingyu Tan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Health Examination and Oncology Screening Center, Chongqing University Cancer Hospital, Chongqing, China. Hauptthemen laut MEDLINE: Adenoma, Liver Cell, Liver Neoplasms. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Examination and Oncology Screening Center, Chongqing University Cancer Hospital, Chongqing, China.
- Hepatobiliary Pancreatic Cancer Center, Chongqing University Cancer Hospital, Chongqing, China.
Zitieren
APA
Tan, J., & Shen, A. (2026). Surgical indications for hepatocellular adenoma: Diagnostic uncertainty and molecular risk stratification. Drug Discoveries & Therapeutics, 20(5), 405-408. https://doi.org/10.5582/ddt.2026.01086
Vancouver
Tan J, Shen A. Surgical indications for hepatocellular adenoma: Diagnostic uncertainty and molecular risk stratification. Drug Discoveries & Therapeutics. 2026;20(5):405-408. doi:10.5582/ddt.2026.01086
BibTeX
@article{Tan2026,
author = {Tan, Jingyu and Shen, Ai},
title = {Surgical indications for hepatocellular adenoma: Diagnostic uncertainty and molecular risk stratification},
journal = {Drug Discoveries & Therapeutics},
year = {2026},
volume = {20},
number = {5},
pages = {405--408},
doi = {10.5582/ddt.2026.01086}
}
EUVIMED